554 Appendices LOH loss of heterozygosity LR likelihood ratio MALDI-MSI matrix-assisted laser desorption ionization / mass spectrometry imaging MAPK mitogen-activated protein kinase mAs milliamperage × seconds MCS mental component score MCT4 monocarboxylate transporter 4 MD molecular diagnostics MeSH Medical Subject Headings mi-OCA minimally invasive OCA MIC minimally important change MIP maximum intensity projection miRNA microRNA mPTC papillary microcarcinoma MRI magnetic resonance imaging MRS magnetic resonance spectroscopy MTC medullary thyroid carcinoma NBIA National Biomedical Imaging Archive NCI National Cancer Institute NGS next generation sequencing NHGRI National Human Genome Research Institute NH-H nodular hyperplasia with oncocytic cell metaplasia NIFTP non-invasive follicular thyroid neoplasm with papillary-like nuclear features NIS sodium-iodide symporter NPV negative predictive value OA oncocytic (thyroid) adenoma, formerly HCA OCA oncocytic (thyroid) carcinoma, formerly HCC OCN oncocytic cell (thyroid) neoplasm, formerly HCN O-FN oncocytic follicular neoplasm OR odds ratio PCR polymerase chain reaction PCS physical component score PET positron emission tomography PET/CT positron emission tomography/computed tomography PPARγ peroxisome proliferator-activated receptor γ PPV positive predictive value PRISMA preferred reporting items for systematic reviews and meta-analyses PTC papillary thyroid carcinoma QALY quality-adjusted life year QUADAS quality assessment of diagnostic accuracy studies RAF rapidly accelerated fibrosarcoma RAI radioactive iodine RAS rat sarcoma virus RCI reciprocal chromosomal imbalance
RkJQdWJsaXNoZXIy MTk4NDMw